SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Medicenna Completes Enrollment in Phase 1/2 MDNA11 Cancer Trial With 152 Patients

Valid market news retained in the public archive without immediate LiveCast distribution.

MRK

Related stories